PT Mitra Keluarga Karyasehat (MIKA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
22 Aug, 2025Executive summary
Operates 30 hospitals with 4,054 operational beds and a 36-year brand heritage, making it one of Indonesia's largest private hospital groups.
Consolidated financial statements for 2024 and 2023 have been audited and present fairly in all material respects, in accordance with Indonesian Financial Accounting Standards.
Achieved 14.3% year-over-year revenue growth in FY24, reaching Rp4.87 trillion, with net income up 23.2% to Rp1.23 trillion.
Maintains a strong focus on operational excellence, expansion, and digital transformation, including a new hospital information system and mobile app.
Recognized with multiple awards for service quality and corporate excellence in 2024.
Financial highlights
FY24 revenue grew 14.3% year-over-year to Rp4.87 trillion; EBITDA increased 22.5% to Rp1.84 trillion, with a margin of 37.7%.
Net income rose 23.2% to Rp1.23 trillion, with a net margin of 25.2%.
Total assets as of December 31, 2024 were Rp8.25 trillion, up from Rp7.34 trillion at year-end 2023.
Basic and diluted earnings per share for 2024 were Rp82.43, up from Rp65.08 in 2023.
ROIC improved to 24.5%, and ROIC excluding land bank reached 39.5%.
Outlook and guidance
Pipeline includes 8 new hospitals with a potential addition of 1,500 beds, plus 851 beds from existing hospitals.
Focus on capacity and intensity expansion, digital innovation, and further acquisitions.
No significant impact is expected from the implementation of new accounting standards effective January 1, 2024.
Latest events from PT Mitra Keluarga Karyasehat
- Net income up 15.6% and revenue up 10.0% year-over-year, with strong expansion and cash growth.MIKA
Q3 20259 Dec 2025 - Strong 1H24 growth in revenue, profit, and margins, with expansion and digital innovation.MIKA
Q2 202422 Aug 2025 - Strong revenue and profit growth with robust margins and continued hospital expansion.MIKA
Q3 202422 Aug 2025 - Revenue and profit rose, margins remained strong, and hospital expansion continued.MIKA
Q1 202522 Aug 2025 - Strong 1H25 growth with rising profit, robust liquidity, and continued hospital expansion.MIKA
Q2 202522 Aug 2025